| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 3.1k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 1.8k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2.4k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2.7k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 3k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 15.6k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 648 | $0.00 | $0 | | 05/31/2023 |
| 03/14/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (Right to Buy) | 432 | $68.50 | $29.6k | | 03/14/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 60 | $28.55 | $1.7k | | 01/04/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 9.5k | $0.00 | $0 | | 01/04/2023 |
| 06/27/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 2.6k | $0.37 | $966.8 | | 06/27/2022 |
| 01/04/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 2.8k | $1.30 | $3.7k | | 01/03/2022 |
| 01/03/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 153k | $1.37 | $209.6k | | 01/03/2022 |
| 10/26/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 9.4k | $1.80 | $17k | | 10/26/2021 |
| 06/28/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 2.5k | $5.77 | $14.1k | | 06/28/2021 |
| 01/04/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 90.7k | $6.86 | $622k | | 01/04/2021 |
| 01/04/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 22.7k | $0.00 | $0 | | 01/04/2021 |
| 10/26/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 61k | $0.00 | $0 | | 10/26/2020 |
| 06/25/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 16k | $0.00 | $0 | | 06/25/2020 |
| 06/19/2020 | Kala Pharmaceuticals, Inc. | KALA | Exercise | Stock Option (right to buy) | 28.9k | $5.19 | $150k | | 06/19/2020 |
| 01/02/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 120k | $3.84 | $460.8k | | 01/02/2020 |
| 10/12/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 100k | $3.45 | $345k | | 10/12/2019 |
| 01/02/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 165k | $5.19 | $856.4k | | 01/02/2019 |
| 04/05/2018 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 150k | $16.62 | $2.5M | | 04/05/2018 |
| 03/19/2018 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 3.5k | $1.70 | $5.9k | | 03/19/2018 |
| 06/23/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Sale | Common Shares, without par value | 7.7k | $1.33 | $10.3k | | 06/23/2017 |